ARTICLE | Management Tracks
Plus: Dubensky to lead ImmuneSensor and updates from NORD and Epsilogen
By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data Content Analyst
May 2, 2024 12:34 AM UTC
Padraig McDonnell is now CEO of Agilent Technologies Inc. (NYSE:A), having been named CEO-elect in February when he was COO. McDonnell joined Agilent in 1997 and succeeds Mike McMullen, who will serve as an adviser until he retires on Oct. 31.
ImmuneSensor Therapeutics Inc. named Thomas Dubensky president and CEO. Dubensky was the founding CEO of Tempest Therapeutics Inc. (NASDAQ:TPST). ImmuneSensor is targeting the cGAS-STING pathway to treat indications in inflammation, autoimmunity and oncology…
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/652299/mcdonnell-now-ceo-of-agilent